Please use this identifier to cite or link to this item:
Title: A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Authors: Joura, Elmar A;Giuliano, Anna R;Iversen, Ole-Erik;Bouchard, Celine;Mao, Constance;Mehlsen, Jesper;Moreira, Edson D;Ngan, Yuen;Petersen, Lone Kjeld;Lazcano-Ponce, Eduardo;Pitisuttithum, Punnee;Restrepo, Jaime Alberto;Stuart, Gavin;Woelber, Linn;Yang, Yuh Cheng;Cuzick, Jack;Garland, Suzanne M;Huh, Warner;Kjaer, Susanne K;Bautista, Oliver M;Chan, Ivan S F;Chen, Joshua;Gesser, Richard;Moeller, Erin;Ritter, Michael;Vuocolo, Scott;Luxembourg, Alain
Year: 19-Feb-2015
Abstract: The investigational 9-valent viruslike particle vaccine against human papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6, 11, 16, and 18) and five additional oncogenic types (31, 33, 45, 52, and 58). Here we present the results of a study of the efficacy and immunogenicity of the 9vHPV vaccine in women 16 to 26 years of age.
ISSN: 10.1056/NEJMoa1405044
Appears in Collections:New England Journal of Medicine 2015

Files in This Item:
File Description SizeFormat 
711.pdf603.47 kBAdobe PDFThumbnail
Download    Request a copy

Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.